The Value of Precision Medicine with James Hamrick, MD and Sanjeev Kumar

In this episode, host Shikha Jain, MD, speaks with James Hamrick, MD, and Sanjeev Kumar about the value of biomarker testing and precision oncology, personal journeys with patient advocacy and more. •    Welcome to another exciting episode of Oncology Overdrive 1:05 •    About Kumar 1:20 •    About Hamrick 1:52 •    The interview 2:30 •    Sanjeev, can you tell us about how you got involved in oncology and immunology?  2:59 •    James, how did you get into this space and start working with Caris Life Sciences? 7:15 •    Sanjeev, how did your mother's experience unfold, and how did you incorporate your personal knowledge help advocate and navigate throughout the situation? 12:00 •    Hamrick and Kumar on the importance of patient advocacy.  17:44 •    Jain, Hamrick and Kumar on the impact precision oncology can have on personalized cancer care. 23:57 •    How do we make current innovations available to everyone? How can we help advocate for patients in rural areas? 28:33 •    Hamrick on how precision oncology helps support decision-making for physicians and community oncologists. 35:13 •    Jain, Hamrick and Kumar on the art and practice of medicine. 40:57 •    If someone could only listen to the last minute of this episode, what would you want listeners to take away? 41:53 •    How to contact Kumar 44:13 •    How to contact Hamrick 44:34 •    Thanks for listening 45:14 James Hamrick, MD, MPH, is the chairman of the Caris Precision Oncology Alliance™ (Caris POA) at Caris Life Sciences.  Sanjeev Kumar is chairman and CEO of the Gallbladder Cancer Foundation, and is a biotech manufacturing leader with a background in immunology from UC Berkeley.  We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Kumar can be reached via email at [email protected], or at the Gallbladder Cancer Foundation website. Hamrick can be reached at the Caris Life Sciences website. Disclosures: Jain and Kumar report no relevant financial disclosures. Hamrick reports being an employee of Caris Life Sciences and an advisor to Community Oncology Partners LLC.